Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
31 results
- 3상모집 중· Depressive Disorder, Treatment-Resistant치료 저항성 우울증 환자에서 에스케타민 비강분무 대 위약 분무 연구
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
리드: 얀센(J&J)
- 3상모집 중· Multiple Myeloma재발 또는 치료 불응성 다발성 골수종 환자에서 JNJ-79635322와 테클리스타맙을 비교하는 연구
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중· Colitis, Ulcerative중등도에서 중증 활동성 궤양성 대장염 환자에서 JNJ-78934804에 관한 연구
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Crohn Disease중등도에서 중증 활동성 크론병 환자에서 JNJ-78934804에 관한 연구
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, Major성인 및 고령 주요우울장애 환자에서 셀토렉산트 단독요법 연구
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Crohn Disease중등도에서 중증 활동성 크론병 환자에서 구셀쿠맙과 리산키주맙 비교 연구
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· Lupus Erythematosus, SystemicA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorA Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
리드: 얀센(J&J)
- 3상모집 중· Myasthenia GravisComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 3상모집 중· Prostatic Neoplasms, Castration-ResistantA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 얀센(J&J)
- 3상모집 중· Squamous Cell Carcinoma of Head and NeckA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
리드: 얀센(J&J)
- 3상모집 중· Colitis, UlcerativeA Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
리드: 얀센(J&J)
- 3상모집 중· Metastatic Castration-resistant Prostatic NeoplasmsA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
리드: 얀센(J&J)
- 3상모집 중· Leukemia, Myeloid, AcuteA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
리드: 얀센(J&J)
- 3상모집 중· Thrombocytopenia, Neonatal AlloimmuneA Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
리드: 얀센(J&J)
- 3상모집 중· Thrombocytopenia, Neonatal AlloimmuneA Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
리드: 얀센(J&J)
- 3상모집 중· Crohns DiseaseA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
리드: 얀센(J&J)
- 3상모집 중· Depressive Disorder, MajorPhase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
리드: 얀센(J&J)
- 3상모집 중· Non-Muscle Invasive Bladder NeoplasmsA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
리드: 얀센(J&J)
- 3상모집 중· Crohn's DiseaseA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중· Hemolytic Disease of the Fetus and NewbornA Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
리드: 얀센(J&J)
- 3상모집 중· Myasthenia GravisA Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 3상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
협력: 아스트라제네카, 얀센(J&J)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.